 | PDH | Name: | (2S)-2-AMINO-3-PHENYL-1-PROPANOL | Formula: | C9 H13 N O | SMILES: | OCC(N)Cc1ccccc1 | InChi: | InChI=1S/C9H13NO/c10-9(7-11)6-8-4-2-1-3-5-8/h1-5,9,11H,6-7,10H2/t9-/m1/s1 | Synonyms: | D-PHENYLALANINOL | Definition date: | 2001-11-16 | Last modified: | 2020-06-17 | Identifier: | (2R)-2-amino-3-phenylpropan-1-ol |
|
 | PDN | Name: | 17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE | Formula: | C21 H26 O5 | SMILES: | O=C2CC4(C(C3CCC1=CC(=O)C=CC1(C)C23)CCC4(O)C(O)=CO)C | InChi: | InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,11,14-15,18,22,25-26H,3-4,6,8,10H2,1-2H3/b17-11-/t14-,15-,18+,19-,20-,21-/m0/s1 | Synonyms: | PREDNISONE | Definition date: | 2001-06-04 | Last modified: | 2020-06-17 | Identifier: | (8alpha,14beta,17alpha,20Z)-17,20,21-trihydroxypregna-1,4,20-triene-3,11-dione |
|
 | PE1 | Name: | N~2~-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4-YL}METHYL)-L-LYSINE | Formula: | C14 H24 N3 O7 P | SMILES: | O=C(O)C(NCc1c(cnc(c1O)C)COP(=O)(O)O)CCCCN | InChi: | InChI=1S/C14H24N3O7P/c1-9-13(18)11(10(6-16-9)8-24-25(21,22)23)7-17-12(14(19)20)4-2-3-5-15/h6,12,17-18H,2-5,7-8,15H2,1H3,(H,19,20)(H2,21,22,23)/t12-/m0/s1 | Synonyms: | PYRIDOXYL-GLUTAMIC ACID-5'-MONOPHOSPHATE | Definition date: | 2004-11-12 | Last modified: | 2020-06-17 | Identifier: | N~2~-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-lysine |
|
 | PE3 | Name: | 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL | Formula: | C28 H58 O15 | SMILES: | O(CCOCCOCCOCCOCCOCCOCCO)CCOCCOCCOCCOCCOCCOCCO | InChi: | InChI=1S/C28H58O15/c29-1-3-31-5-7-33-9-11-35-13-15-37-17-19-39-21-23-41-25-27-43-28-26-42-24-22-40-20-18-38-16-14-36-12-10-34-8-6-32-4-2-30/h29-30H,1-28H2 | Synonyms: | POLYETHYLENE GLYCOL | Definition date: | 2004-11-04 | Last modified: | 2020-06-17 | Identifier: | 3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxahentetracontane-1,41-diol |
|
 | PE4 | Name: | 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL | Formula: | C16 H34 O8 | SMILES: | O(CCOCCO)CCOCCOCCOCCOCCOCC | InChi: | InChI=1S/C16H34O8/c1-2-18-5-6-20-9-10-22-13-14-24-16-15-23-12-11-21-8-7-19-4-3-17/h17H,2-16H2,1H3 | Synonyms: | POLYETHYLENE GLYCOL PEG4000 | Definition date: | 2003-08-18 | Last modified: | 2020-06-17 | Identifier: | 3,6,9,12,15,18,21-heptaoxatricosan-1-ol |
|
 | PEV | Name: | (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | Formula: | C39 H78 N O8 P | SMILES: | O=C(OCC(OC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(OCCN)O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C39H78NO8P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-39(42)48-37(36-47-49(43,44)46-34-33-40)35-45-38(41)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h37H,3-36,40H2,1-2H3,(H,43,44)/t37-/m0/s1 | Synonyms: | PHOSPHATIDYLETHANOLAMINE | Definition date: | 2006-07-06 | Last modified: | 2020-06-17 | Identifier: | (1S)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl octadecanoate |
|
 | PEW | Name: | (1R)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (9S,10S)-9,10-DIBROMOOCTADECANOATE | Formula: | C39 H76 Br2 N O8 P | SMILES: | BrC(CCCCCCCC)C(Br)CCCCCCCC(=O)OC(COP(=O)(OCCN)O)COC(=O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C39H76Br2NO8P/c1-3-5-7-9-11-12-13-14-15-16-17-21-25-29-38(43)47-33-35(34-49-51(45,46)48-32-31-42)50-39(44)30-26-22-18-20-24-28-37(41)36(40)27-23-19-10-8-6-4-2/h35-37H,3-34,42H2,1-2H3,(H,45,46)/t35-,36+,37+/m1/s1 | Synonyms: | DIBROMINATED PHOSPHATIDYLETHANOLAMINE | Definition date: | 2006-07-06 | Last modified: | 2020-06-17 | Identifier: | (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9S,10S)-9,10-dibromooctadecanoate |
|
 | PF3 | Name: | (2R)-3-({[4-[(PYRIDIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID | Formula: | C25 H20 N2 O3 S | SMILES: | O=C(O)CC(c1ccccc1)NC(=O)c4scc(c3ccc(c2ccncc2)cc3)c4 | InChi: | InChI=1S/C25H20N2O3S/c28-24(29)15-22(20-4-2-1-3-5-20)27-25(30)23-14-21(16-31-23)18-8-6-17(7-9-18)19-10-12-26-13-11-19/h1-14,16,22H,15H2,(H,27,30)(H,28,29)/t22-/m1/s1 | Synonyms: | PF-00356231 | Definition date: | 2003-12-12 | Last modified: | 2020-06-17 | Identifier: | (3R)-3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thiophen-2-yl]carbonyl}amino)propanoic acid |
|
 | PFL | Name: | 2,6-BIS(1-METHYLETHYL)PHENOL | Formula: | C12 H18 O | SMILES: | Oc1c(cccc1C(C)C)C(C)C | InChi: | InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | Synonyms: | 2,6-DIISOPROPYLPHENOL | Definition date: | 2000-08-29 | Last modified: | 2020-06-17 | Identifier: | 2,6-bis(1-methylethyl)phenol |
|
 | PFM | Name: | 1-AMINO-7-(2-METHYL-3-OXIDO-5-((PHOSPHONOXY)METHYL)-4-PYRIDOXAL-5-OXO-6-HEPTENATE | Formula: | C14 H19 N2 O8 P | SMILES: | O=C(O)C(N)C/C=C(O)/C=C/c1c(cnc(c1O)C)COP(=O)(O)O | InChi: | InChI=1S/C14H19N2O8P/c1-8-13(18)11(9(6-16-8)7-24-25(21,22)23)4-2-10(17)3-5-12(15)14(19)20/h2-4,6,12,17-18H,5,7,15H2,1H3,(H,19,20)(H2,21,22,23)/b4-2+,10-3-/t12-/m0/s1 | Synonyms: | PYRIDOXYLIDENE-PROPEN-1-YL-3-ALANINE-5-PHOSPHATE | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | (2S,4Z,6E)-2-amino-5-hydroxy-7-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}hepta-4,6-dienoic acid |
|
 | PFN | Name: | FENOPROFEN | Formula: | C15 H14 O3 | SMILES: | O=C(O)C(c2cc(Oc1ccccc1)ccc2)C | InChi: | InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)/t11-/m1/s1 | Synonyms: | (2R)-2-(3-PHENOXYPHENYL)PROPANOIC ACID | Definition date: | 2010-02-26 | Last modified: | 2020-06-17 | Identifier: | (2R)-2-(3-phenoxyphenyl)propanoic acid |
|
 | PFS | Name: | (2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate | Formula: | C26 H54 N O7 P | SMILES: | [O-]P(=O)(OCC(OC(=O)C)COCCCCCCCCCCCCCCCC)OCC[N+](C)(C)C | InChi: | InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1 | Synonyms: | PLATELET ACTIVATING FACTOR | Definition date: | 2004-07-15 | Last modified: | 2020-06-17 | Identifier: | (2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate |
|
 | PFU | Name: | (1S)-1,4-anhydro-1-(5-carbamoyl-4-hydroxy-1H-pyrazol-3-yl)-5-O-phosphono-D-ribitol | Formula: | C9 H14 N3 O9 P | SMILES: | O=C(N)c1c(O)c(nn1)C2OC(COP(=O)(O)O)C(O)C2O | InChi: | InChI=1S/C9H14N3O9P/c10-9(16)4-6(14)3(11-12-4)8-7(15)5(13)2(21-8)1-20-22(17,18)19/h2,5,7-8,13-15H,1H2,(H2,10,16)(H,11,12)(H2,17,18,19)/t2-,5-,7-,8+/m1/s1 | Synonyms: | Pyrazofurin Monophosphate | Definition date: | 2010-04-13 | Last modified: | 2020-06-17 | Identifier: | (1S)-1,4-anhydro-1-(5-carbamoyl-4-hydroxy-1H-pyrazol-3-yl)-5-O-phosphono-D-ribitol |
|
 | PG0 | Name: | 2-(2-METHOXYETHOXY)ETHANOL | Formula: | C5 H12 O3 | SMILES: | OCCOCCOC | InChi: | InChI=1S/C5H12O3/c1-7-4-5-8-3-2-6/h6H,2-5H2,1H3 | Synonyms: | PEG 6000 | Definition date: | 2005-06-02 | Last modified: | 2020-06-17 | Identifier: | 2-(2-methoxyethoxy)ethanol |
|
 | PG2 | Name: | PROSTAGLANDIN D2 | Formula: | C20 H32 O5 | SMILES: | O=C1CC(O)C(CC=C/CCCC(=O)O)C1/C=C/C(O)CCCCC | InChi: | InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-/m0/s1 | Synonyms: | (5E,13E)-9,15-DIHYDROXY-11-OXOPROSTA-5,13-DIEN-1-OIC ACID | Definition date: | 2004-01-06 | Last modified: | 2020-06-17 | Identifier: | (5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid |
|
 | PGG | Name: | PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE | Formula: | C12 H15 N2 O8 P | SMILES: | O=P(Oc1ccc(cc1)[N+]([O-])=O)(O)CCCC(=O)NCC(=O)O | InChi: | InChI=1S/C12H15N2O8P/c15-11(13-8-12(16)17)2-1-7-23(20,21)22-10-5-3-9(4-6-10)14(18)19/h3-6H,1-2,7-8H2,(H,13,15)(H,16,17)(H,20,21) | Synonyms: | N-PYRIDOXYL-3-[2-AMINO-ETHOXY-METHYLENE]ALANINE-5-MONOPHOSPHATE | Definition date: | 1999-09-13 | Last modified: | 2020-06-17 | Identifier: | N-{4-[(R)-hydroxy(4-nitrophenoxy)phosphoryl]butanoyl}glycine |
|
 | PGK | Name: | (1R)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL
(9S,10S)-9,10-DIBROMOOCTADECANOATE | Formula: | C40 H77 Br2 O10 P | SMILES: | BrC(CCCCCCCC)C(Br)CCCCCCCC(=O)OC(COP(=O)(OCC(O)CO)O)COC(=O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C40H77Br2O10P/c1-3-5-7-9-11-12-13-14-15-16-17-21-25-29-39(45)49-33-36(34-51-53(47,48)50-32-35(44)31-43)52-40(46)30-26-22-18-20-24-28-38(42)37(41)27-23-19-10-8-6-4-2/h35-38,43-44H,3-34H2,1-2H3,(H,47,48)/t35-,36-,37+,38+/m1/s1 | Synonyms: | DIBROMINATED PHOSPHATIDYLGLYCEROL | Definition date: | 2006-07-06 | Last modified: | 2020-06-17 | Identifier: | (1R)-2-{[(S)-{[(2R)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9S,10S)-9,10-dibromooctadecanoate |
|
 | PGT | Name: | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | Formula: | C40 H79 O10 P | SMILES: | O=C(OCC(OC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(OCC(O)CO)O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C40H79O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h37-38,41-42H,3-36H2,1-2H3,(H,45,46)/t37-,38+/m1/s1 | Synonyms: | PHOSPHATIDYLGLYCEROL | Definition date: | 2006-07-06 | Last modified: | 2020-06-17 | Identifier: | (1S)-2-{[(S)-{[(2R)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl octadecanoate |
|
 | PGW | Name: | (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl
(9Z)-octadec-9-enoate | Formula: | C40 H77 O10 P | SMILES: | O=C(OC(COP(=O)(OCC(O)CO)O)COC(=O)CCCCCCCCCCCCCCC)CCCCCCCC=C/CCCCCCCC | InChi: | InChI=1S/C40H77O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,37-38,41-42H,3-16,19-36H2,1-2H3,(H,45,46)/b18-17-/t37-,38+/m0/s1 | Synonyms: | 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-(1-glycerol)] | Definition date: | 2007-11-02 | Last modified: | 2020-06-17 | Identifier: | (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate |
|
 | PHU | Name: | 1-phenylurea | Formula: | C7 H8 N2 O | SMILES: | O=C(Nc1ccccc1)N | InChi: | InChI=1S/C7H8N2O/c8-7(10)9-6-4-2-1-3-5-6/h1-5H,(H3,8,9,10) | Synonyms: | Phenylurea | Definition date: | 2011-06-24 | Last modified: | 2020-06-17 | Identifier: | 1-phenylurea |
|
 | PI2 | Name: | 2-{11-[1-HYDROXY-2-(3-METHYL-BUTYLAMINO)-ETHYL] -6,9-DIOXO-2-OXA-7,10-DIAZA-BICYCLO[11.2.2]HEPTADECA-
1(16),13(17),14-TRIEN-8-YL}-ACETAMIDE | Formula: | C23 H36 N4 O5 | SMILES: | O=C1NC(C(O)CNCCC(C)C)Cc2ccc(OCCCC(=O)NC1CC(=O)N)cc2 | InChi: | InChI=1S/C23H36N4O5/c1-15(2)9-10-25-14-20(28)18-12-16-5-7-17(8-6-16)32-11-3-4-22(30)26-19(13-21(24)29)23(31)27-18/h5-8,15,18-20,25,28H,3-4,9-14H2,1-2H3,(H2,24,29)(H,26,30)(H,27,31)/t18-,19-,20+/m0/s1 | Synonyms: | MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2 | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 2-[(8S,11S)-11-{(1R)-1-hydroxy-2-[(3-methylbutyl)amino]ethyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-yl]acetamide |
|
 | PI3 | Name: | 11-[1-HYDROXY-2-(3-METHYL-BUTYLAMINO)-ETHYL]-8-ISOPROPYL-2-OXA-7,10-
DIAZA-BICYCLO[11.2.2]HEPTADECA-1(16),13(17),14-TRIENE-6,9-DIONE | Formula: | C24 H39 N3 O4 | SMILES: | O=C1NC(C(O)CNCCC(C)C)Cc2ccc(OCCCC(=O)NC1C(C)C)cc2 | InChi: | InChI=1S/C24H39N3O4/c1-16(2)11-12-25-15-21(28)20-14-18-7-9-19(10-8-18)31-13-5-6-22(29)27-23(17(3)4)24(30)26-20/h7-10,16-17,20-21,23,25,28H,5-6,11-15H2,1-4H3,(H,26,30)(H,27,29)/t20-,21+,23-/m0/s1 | Synonyms: | MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3 | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | (8S,11S)-11-{(1R)-1-hydroxy-2-[(3-methylbutyl)amino]ethyl}-8-(1-methylethyl)-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-triene-6,9-dione |
|
 | PI7 | Name: | N-[3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2]
HEPTADECA-1(16),13(17),14-TRIEN-11-YAMINO)-2-HYDROXY-1-(4-HYDROXY-BENZYL) -PROPYL]-3-METHYL-2-PROPIONYLAMINO-BUTYRAMIDE | Formula: | C36 H53 N5 O7 | SMILES: | O=C(NC(C(=O)NC(Cc1ccc(O)cc1)C(O)CNC3C(=O)NC(C(=O)NCCCOc2ccc(cc2)C3)C(C)CC)C(C)C)CC | InChi: | InChI=1S/C36H53N5O7/c1-6-23(5)33-35(46)37-17-8-18-48-27-15-11-25(12-16-27)20-29(34(45)41-33)38-21-30(43)28(19-24-9-13-26(42)14-10-24)39-36(47)32(22(3)4)40-31(44)7-2/h9-16,22-23,28-30,32-33,38,42-43H,6-8,17-21H2,1-5H3,(H,37,46)(H,39,47)(H,40,44)(H,41,45)/t23-,28-,29-,30+,32-,33-/m0/s1 | Synonyms: | MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | N-[(1S,2R)-2-hydroxy-1-(4-hydroxybenzyl)-3-{[(8S,11S)-8-[(1S)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}propyl]-N~2~-propanoyl-L-valinamide |
|
 | PIB | Name: | 2-(BUTANOYLOXY)-1-{[(HYDROXY{[2,3,4,6-TETRAHYDROXY-5-(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL)OXY]METHYL}ETHYL
BUTANOATE | Formula: | C17 H32 O16 P2 | SMILES: | O=C(OCC(OC(=O)CCC)COP(=O)(OC1C(O)C(O)C(O)C(OP(=O)(O)O)C1O)O)CCC | InChi: | InChI=1S/C17H32O16P2/c1-3-5-10(18)29-7-9(31-11(19)6-4-2)8-30-35(27,28)33-17-14(22)12(20)13(21)16(15(17)23)32-34(24,25)26/h9,12-17,20-23H,3-8H2,1-2H3,(H,27,28)(H2,24,25,26)/t9-,12-,13-,14+,15+,16+,17-/m0/s1 | Synonyms: | D-MYO-PHOSPHATIDYLINOSITOL 3-PHOSPHATED (+)-SN-1,2-DI-O-BUTANOYLGLYCERYL,3-O-PHOSPHO | Definition date: | 2001-06-15 | Last modified: | 2020-06-17 | Identifier: | (2S)-3-{[(S)-hydroxy{[(1S,2R,3S,4S,5R,6R)-2,3,4,6-tetrahydroxy-5-(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dibutanoate |
|
 | PIN | Name: | PIPERAZINE-N,N'-BIS(2-ETHANESULFONIC ACID) | Formula: | C8 H18 N2 O6 S2 | SMILES: | O=S(=O)(O)CCN1CCN(CCS(=O)(=O)O)CC1 | InChi: | InChI=1S/C8H18N2O6S2/c11-17(12,13)7-5-9-1-2-10(4-3-9)6-8-18(14,15)16/h1-8H2,(H,11,12,13)(H,14,15,16) | Synonyms: | PIPES | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 2,2'-piperazine-1,4-diyldiethanesulfonic acid |
|